HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 19,100
-600 (-3.05%)
At close: Jul 27, 2026
HansBiomed Balance Sheet
Financials in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 17,954 | 8,149 | 7,259 | 6,132 | 7,524 | 7,051 |
Trading Asset Securities | - | - | - | 916.26 | 6,030 | 13,217 |
Cash & Short-Term Investments | 17,954 | 8,149 | 7,259 | 7,048 | 13,553 | 20,268 |
Cash Growth | 52.83% | 12.26% | 3.00% | -48.00% | -33.13% | -11.35% |
Accounts Receivable | 23,187 | 16,646 | 11,246 | 12,091 | 9,561 | 7,337 |
Other Receivables | 895.96 | 595.04 | 646.92 | 779.81 | 459.59 | 2,388 |
Receivables | 26,912 | 17,280 | 11,933 | 12,903 | 10,223 | 9,803 |
Inventory | 29,400 | 28,833 | 28,342 | 27,798 | 26,936 | 18,673 |
Prepaid Expenses | - | 794.65 | 557.28 | 733.24 | 579.89 | 433.2 |
Other Current Assets | 3,507 | 1,015 | 1,616 | 1,911 | 3,079 | 1,935 |
Total Current Assets | 77,773 | 56,072 | 49,707 | 50,393 | 54,371 | 51,113 |
Property, Plant & Equipment | 42,000 | 41,724 | 43,523 | 44,234 | 46,934 | 46,591 |
Long-Term Investments | 5,446 | 5,728 | 5,262 | 4,356 | 6,222 | 8,926 |
Other Intangible Assets | 501.18 | 535.75 | 794.97 | 755.83 | 899.8 | 1,031 |
Long-Term Accounts Receivable | 2,741 | 2,375 | 236.81 | 0 | - | - |
Long-Term Deferred Tax Assets | 328.57 | 328.57 | 2,202 | 2,318 | 2,636 | 734.37 |
Long-Term Deferred Charges | - | - | - | - | - | 89.19 |
Other Long-Term Assets | 19,102 | 19,588 | 19,788 | 20,132 | 20,464 | 20,756 |
Total Assets | 147,935 | 126,407 | 121,715 | 122,368 | 131,686 | 129,445 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 6,601 | 5,399 | 2,274 | 2,114 | 1,984 | 1,204 |
Accrued Expenses | 2,025 | 1,459 | 1,096 | 947.38 | 841.76 | 743.93 |
Short-Term Debt | 34,300 | 35,300 | 34,300 | 39,450 | 53,553 | 27,300 |
Current Portion of Long-Term Debt | - | - | - | - | - | 9,000 |
Current Portion of Leases | 847.66 | 807.33 | 1,130 | 942.13 | 1,010 | 740.52 |
Current Income Taxes Payable | 649.12 | 509.95 | 848.17 | 109.47 | 320.37 | - |
Other Current Liabilities | 18,205 | 37,560 | 10,445 | 21,691 | 16,734 | 22,002 |
Total Current Liabilities | 62,629 | 81,034 | 50,092 | 65,253 | 74,443 | 60,991 |
Long-Term Debt | 6,000 | 6,000 | - | - | - | 12,879 |
Long-Term Leases | 1,078 | 1,199 | 1,000 | 749.26 | 1,347 | 1,658 |
Other Long-Term Liabilities | 4,251 | 4,287 | 3,501 | 6,417 | 8,441 | 6,336 |
Total Liabilities | 73,958 | 92,521 | 54,593 | 72,419 | 84,231 | 81,863 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 7,131 | 6,763 | 6,763 | 6,058 | 5,051 | 5,051 |
Additional Paid-In Capital | 112,382 | 82,224 | 82,224 | 58,621 | 32,288 | 32,288 |
Retained Earnings | -40,304 | -46,323 | -14,982 | -7,759 | 15,286 | 9,139 |
Treasury Stock | - | -5,833 | -5,833 | -5,833 | -5,055 | -884.32 |
Comprehensive Income & Other | -4,995 | -3,127 | -1,298 | -1,958 | -1,937 | -1,143 |
Total Common Equity | 74,214 | 33,704 | 66,874 | 49,129 | 45,634 | 44,451 |
Minority Interest | -237.35 | 182.7 | 248.39 | 819.76 | 1,821 | 3,130 |
Shareholders' Equity | 73,977 | 33,887 | 67,122 | 49,949 | 47,455 | 47,581 |
Total Liabilities & Equity | 147,935 | 126,407 | 121,715 | 122,368 | 131,686 | 129,445 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 42,226 | 43,307 | 36,430 | 41,141 | 55,910 | 51,577 |
Net Cash (Debt) | -24,272 | -35,158 | -29,171 | -34,093 | -42,356 | -31,309 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1811.05 | -2707.17 | -2252.56 | -3181.12 | -3224.39 | -3127.17 |
Filing Date Shares Outstanding | 14.26 | 12.99 | 12.99 | 11.58 | 9.64 | 10.01 |
Total Common Shares Outstanding | 14.26 | 12.99 | 12.99 | 11.58 | 9.64 | 10.01 |
Working Capital | 15,144 | -24,963 | -385.31 | -14,860 | -20,072 | -9,878 |
Book Value Per Share | 5203.85 | 2595.20 | 5149.32 | 4243.81 | 4732.03 | 4439.82 |
Tangible Book Value | 73,713 | 33,168 | 66,079 | 48,373 | 44,734 | 43,420 |
Tangible Book Value Per Share | 5168.71 | 2553.95 | 5088.10 | 4178.52 | 4638.72 | 4336.84 |
Land | 12,753 | 12,571 | 12,459 | 12,542 | 12,525 | 12,525 |
Buildings | 22,356 | 22,086 | 21,925 | 22,049 | 17,649 | 18,110 |
Machinery | 23,266 | 22,402 | 20,998 | 19,869 | 8,920 | 7,919 |
Construction In Progress | 1,568 | 1,429 | 1,535 | 1,262 | 1,043 | 1,603 |